行情

LPCN

LPCN

Lipocine
NASDAQ

实时行情|Nasdaq Last Sale

0.3701
-0.0239
-6.07%
盘后: 0.3700 -0.0001 -0.03% 17:42 12/11 EST
开盘
0.3950
昨收
0.3940
最高
0.3997
最低
0.3520
成交量
92.17万
成交额
--
52周最高
3.450
52周最低
0.3520
市值
940.13万
市盈率(TTM)
-0.6735
分时
5日
1月
3月
1年
5年

分析师评级

2位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

LPCN 新闻

  • Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lipocine, Armstrong Flooring, Wanda Sports Group, and Canopy Growth and Encourages Investors to Contact the Firm
  • PR Newswire.9小时前
  • IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Lipocine Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
  • ACCESSWIRE.9小时前
  • INVESTOR CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in Lipocine, Inc., Armstrong Flooring, Inc., and Grubhub, Inc. of Filing Deadlines
  • GlobeNewswire.1天前
  • SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lipocine Inc. of Class Action Lawsuit and Upcoming Deadline - LPCN
  • ACCESSWIRE.2天前

更多

所属板块

生物技术和医学研究
-0.34%
制药与医学研究
+0.06%

热门股票

名称
价格
涨跌幅

LPCN 简况

Lipocine Inc. is a specialty pharmaceutical company. The Company is focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men's and women's health. Its primary development programs are based on oral delivery solutions for bioavailable drugs. Its lead product candidate, LPCN 1021, is an oral testosterone replacement therapy (TRT), designed for twice-a-day dosing and is in Phase III testing. The Company's additional pipeline candidates include LPCN 1111, an oral testosterone therapy product targeted for once daily dosing, which is in Phase II testing, and LPCN 1107, an oral therapy for the prevention of preterm birth, which is in Phase I testing. These products are based on its Lip'ral promicellar drug delivery technology platform. Lip'ral promicellar technology is a technology based on lipidic compositions, which form an optimal dispersed phase in the gastrointestinal environment for improved absorption of insoluble drugs.
展开

Webull提供Lipocine Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。